Key statistics
On Friday, Aldeyra Therapeutics Inc (137:STU) closed at 4.83, -15.19% below its 52-week high of 5.70, set on Sep 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.70 |
---|---|
High | 4.86 |
Low | 4.70 |
Bid | 4.85 |
Offer | 4.90 |
Previous close | 4.61 |
Average volume | 750.00 |
---|---|
Shares outstanding | 59.42m |
Free float | 48.69m |
P/E (TTM) | -- |
Market cap | 317.31m USD |
EPS (TTM) | -0.6387 USD |
Data delayed at least 15 minutes, as of Oct 04 2024.
More ▼
Press releases
- Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
- Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
- Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap